Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,079 GBX | -0.72% | -2.26% | +14.06% |
05-16 | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
05-16 | Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.06% | 239B | |
+32.40% | 694B | |
+29.39% | 593B | |
-1.67% | 371B | |
+19.96% | 331B | |
+6.61% | 290B | |
-3.15% | 209B | |
+9.89% | 209B | |
+8.03% | 169B | |
-0.68% | 164B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : JP Morgan reiterates its Buy rating